The clearest signal from trading on Monday, August 10, 2026 did not come from the benchmark itself, but from a smaller name: ODIN Investments surged 14.7% to EGP 3.27 even as the EGX 30 index fell 0.45% to 54,876 points. That divergence points to a highly selective rotation into healthcare-linked names and defensive demand stories, at a time when USD/EGP edged up again to 49.83 and Brent crude climbed 4.5% on the day to $87.28 a barrel.
Key figures
- ODIN: +14.7% at EGP 3.27
- EGX 30: -0.45% at 54,876
- PHAR: +20.0% on EGP 1.73bn turnover
- Ibnsina Pharma: +5.6% on EGP 411.4m turnover
- USD/EGP: 49.83, up 0.35%
Market context: a weaker index, but strong internal rotation
On the , market breadth was negative but not uniformly weak: , , and out of tracked. That explains the headline decline in the EGX 30, yet it also hides a sharp concentration of flows into a narrow set of themes, especially pharmaceuticals, drug distribution, and selected domestic plays.